Report Summary
Eternity Insights has published a new study on Global Hematopoietic Stem Cell Transplantation (HSCT) Market focusing on key segments as by Type (Allogeneic,Autologous, Other), by Application (Peripheral Blood Stem Cells Transplant (PBSCT),Bone Marrow Transplant (BMT),Cord Blood Transplant (CBT), Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Hematopoietic Stem Cell Transplantation (HSCT) Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Hematopoietic Stem Cell Transplantation (HSCT) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Segmentation:
Hematopoietic Stem Cell Transplantation (HSCT) Market, By Type
- Allogeneic
- Autologous
- Other
Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Bone Marrow Transplant (BMT)
- Cord Blood Transplant (CBT)
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Hematopoietic Stem Cell Transplantation (HSCT) market in terms of demand generation. The Hematopoietic Stem Cell Transplantation (HSCT) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Hematopoietic Stem Cell Transplantation (HSCT) market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Taxonomy:
To learn more about this report
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Competitive Landscape
The global Hematopoietic Stem Cell Transplantation (HSCT) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Regen Biopharma Inc
- China Cord Blood Corp
- CBR Systems Inc
- Escape Therapeutics Inc
- Cryo-Save AG
- Lonza Group Ltd
- Pluristem Therapeutics Inc
- ViaCord Inc
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Allogeneic,Autologous, Other |
| By Application Outlook |
Peripheral Blood Stem Cells Transplant (PBSCT),Bone Marrow Transplant (BMT),Cord Blood Transplant (CBT), Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Regen Biopharma Inc,China Cord Blood Corp,CBR Systems Inc,Escape Therapeutics Inc,Cryo-Save AG,Lonza Group Ltd,Pluristem Therapeutics Inc,ViaCord Inc |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Hematopoietic Stem Cell Transplantation (HSCT) Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Hematopoietic Stem Cell Transplantation (HSCT) Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Allogeneic Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Autologous Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Type
8.1 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Application (Consumption and Market Share)
8.2 North America Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Application (Consumption and Market Share)
8.3 Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Application (Consumption and Market Share)
8.4 South America Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Regen Biopharma Inc
9.1.1 Regen Biopharma Inc Profiles
9.1.2 Regen Biopharma Inc Product Portfolio
9.1.3 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.1.4 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
9.2 China Cord Blood Corp
9.2.1 China Cord Blood Corp Profiles
9.2.2 China Cord Blood Corp Product Portfolio
9.2.3 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.2.4 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
9.3 CBR Systems Inc
9.3.1 CBR Systems Inc Profiles
9.3.2 CBR Systems Inc Product Portfolio
9.3.3 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.3.4 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
9.4 Escape Therapeutics Inc
9.4.1 Escape Therapeutics Inc Profiles
9.4.2 Escape Therapeutics Inc Product Portfolio
9.4.3 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.4.4 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
9.5 Cryo-Save AG
9.5.1 Cryo-Save AG Profiles
9.5.2 Cryo-Save AG Product Portfolio
9.5.3 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.5.4 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
9.6 Lonza Group Ltd
9.6.1 Lonza Group Ltd Profiles
9.6.2 Lonza Group Ltd Product Portfolio
9.6.3 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.6.4 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
9.7 Pluristem Therapeutics Inc
9.7.1 Pluristem Therapeutics Inc Profiles
9.7.2 Pluristem Therapeutics Inc Product Portfolio
9.7.3 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.7.4 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
9.8 ViaCord Inc
9.8.1 ViaCord Inc Profiles
9.8.2 ViaCord Inc Product Portfolio
9.8.3 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Performance
9.8.4 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Business Development and Market Status
10 World Hematopoietic Stem Cell Transplantation (HSCT) Market Assessment by Players
10.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Hematopoietic Stem Cell Transplantation (HSCT) Price (USD/Unit) of Players 2014-2020
10.4 Global Hematopoietic Stem Cell Transplantation (HSCT) Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Sales Assessment of Players 2014-2020
11.1.2 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Assessment of Players 2014-2020
11.1.3 North America Hematopoietic Stem Cell Transplantation (HSCT) Price Assessment of Players 2014-2020
11.1.4 North America Hematopoietic Stem Cell Transplantation (HSCT) Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Hematopoietic Stem Cell Transplantation (HSCT) Sales Assessment of Players 2014-2020
11.2.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Hematopoietic Stem Cell Transplantation (HSCT) Price Assessment of Players 2014-2020
11.2.4 Europe Hematopoietic Stem Cell Transplantation (HSCT) Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Hematopoietic Stem Cell Transplantation (HSCT) Sales Assessment of Players 2014-2020
11.4.2 South America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Assessment of Players 2014-2020
11.4.3 South America Hematopoietic Stem Cell Transplantation (HSCT) Price Assessment of Players 2014-2020
11.4.4 South America Hematopoietic Stem Cell Transplantation (HSCT) Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries/Regions 2014-2020
12.2.2 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries/Regions 2014-2020
12.2.3 North America Hematopoietic Stem Cell Transplantation (HSCT) Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries/Regions 2014-2020
12.3.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries/Regions 2014-2020
12.3.3 Europe Hematopoietic Stem Cell Transplantation (HSCT) Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries/Regions 2014-2020
12.4.2 South America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries/Regions 2014-2020
12.4.3 South America Hematopoietic Stem Cell Transplantation (HSCT) Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Hematopoietic Stem Cell Transplantation (HSCT) Sales & Revenue Forecast 2021-2026
14.1 World Hematopoietic Stem Cell Transplantation (HSCT) Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Hematopoietic Stem Cell Transplantation (HSCT)Sales and Market Share by Regions
14.1.2 World Hematopoietic Stem Cell Transplantation (HSCT)Revenue and Market Share by Regions
15 Asia Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Allogeneic
15.1.2 Autologous
15.2 Consumption Forecast by Application, 2021-2026
16 North America Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Allogeneic
16.1.2 Autologous
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Allogeneic
17.1.2 Autologous
17.2 Consumption Forecast by Application, 2021-2026
18 South America Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Allogeneic
18.1.2 Autologous
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Allogeneic
19.1.2 Autologous
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Price (USD/Unit) Trend 2021-2026
20.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Gross Profit Trend 2021-2026
21 Conclusion
